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Lymphocytosis rarely accompanies acute bacterial disease. A striking excep- 
tion is found in many cases of whooping cough, as first noted by Fr6hlich in 
1897  (1).  In  patients with pertussis  the  peripheral  leucocyte count may be 
greater than 175,000/mmL and the majority of ceils are usually morphologically 
normal small lymphocytes. Despite clinical familiarity with the phenomenon, 
comparatively little is known regarding the nature of the component of Borde- 
tella pertussls that induces this unique response. It is known that active disease 
is not prerequisite since lymphocytosis occurs following the injection of killed 
pertnssis vaccine into man (2) and experimental animals (3); sonic extracts of 
the bacterium have also been reported to induce lymphocytosis, but the active 
factor has not been defined (4). The dynamics of the response in the host have 
also not been delineated and it is not certain whether the increase in circulating 
lymphocytes is the result of increased production of ceils or a  consequence of 
mobilization of cells from lymphoid and other tissues. It is apparent that an 
understanding of the mechanism by which B. pertussis induces lymphocytosis 
might extend our comprehension of the regulation and control of the level of 
circulating lymphocytes. 
The results of studies on the leucocytosis, particularly the lymphocytosis, 
produced in mice by injecting pertussis vaccine are presented in this report. 
Sequential changes in the quantity and kinds of leucocytes in  the  circulation 
after inoculation of animals with vaccine were examined. The properties of the 
vaccine which made it effective in producing leucocytosis were also analyzed. 
The histopathology of tissues of mice injected with pertussis vaccine suggested 
that lymphocytosis may result primarily from release of ceils into the circula- 
tion from tissue depots, particularly the lymphoid organs. 
Materials and Methods 
Mice.--Four- to 6-week-old NCS mice (5) of both sexes were utilized. During the latter 
part of the study many of these specific  pathogen-free  mice were found to c~rry Esckeridda 
coli and  such contaminated animals responded somewhat differently to  the injection of 
pertussis vaccine (see Results). 
* This investigation was supported by research grant AI-04648-02, from the National 
Institute of Allergy  and Infectious  Diseases, Public Health Service. 
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Pertu~sis Vaccine.--Commercially available  pertussis  vaccine  (Eli Lilly and  Company, 
Indianapolis) containing 50 to I00 X  109 phase I organisms/ml,  suspended in physiological 
saline with  l:10,000  thimerosal, was initially used. Concentrated  suspensions of the killed 
organisms were also kindly supplied by Dr. J. M. McGuire of Eli Lilly and Company. Before 
injection these were diluted to achieve the same concentration  of organisms as in the con- 
ventional preparations. 
Leucocyte Counts (WBC).--Blood for peripheral leucocyte counts was obtained by severing 
the tail a few millimeters from the distal end. Differential counts were performed on Wright- 
stained  films. It was frequently  di~cult to distinguish  monocytes from large lymphocytes 
and only those cells which were typical  monocytes were classified as such. Cells were also 
classified as polymorphonuclear leucocytes  (PMN's),  small lymphocytes  and  large mono- 
nuclear cells (including both monocytes and large lymphocytes) by direct examination in the 
counting chamber using )<430 and phase contrast objectives. The wet differential count was 
reproducible, correlated well with stained films, and had the advantage  of achieving repre- 
sentative  cell distribution.  Unless otherwise indicated  4 to 6 mice were utilized  for each 
determination. 
Agglutination Tests.---0.2 ml of serum was serially diluted twofold in phosphate-buffered 
saline, pH 7.2, in plastic cups. 0.2 ml of vaccine diluted  1:2 in the same buffer with 10 per 
cent  normal  rabbit  serum  was added  and  the degree of agglutination  was recorded after 
90 minutes at 25°C. 
Operative Procedures.--Thymectomy was performed under light ether  anesthesia  by the 
method of Kaplan (6). Imtraperitoneal pentobarbital  was the anesthetic agent for splenectomy. 
The excellent technical assistance of Marie B. Picard is gratefully acknowledged. 
RESULTS 
Peripheral  Leucocyte Counts of Mice  Injected  Intravenously  with  Pertussis 
Vaccine.--Mice were injected intravenously v/a a  lateral  tail vein with either 
0.3, 0.1, or 0.05 ml of pertussis vaccine. The lower doses were brought to 0.3 ml 
volume  with  diluent  (physiologic  saline  containing  1:10,000  thimerosal); 
another group of mice received 0.3 ml of diluent alone. WBC's were then per- 
formed at specified intervals. 
As depicted in Fig.  1, striking leucocytosis occurred in all animals receiving 
the vaccine. At the higher doses, an elevation in white cell count was apparent 
within 24 hours and the peak response for all groups was 3 to 5 days after injec- 
tion.  At  the  height  of  the  leucocytosis  following  the  injection  of 0.3  ml  of 
pertussis  vaccine,  there  were  between  135,000  and  200,000  circulating  white 
cells/ram  3. The counts remained elevated for more than 2 weeks. More concen- 
trated vaccine did not result in significantly greater leucocytosis indicating that 
0.3  ml  was  a  maximum  dose.  Since  animals  receiving  diluent  alone  did  not 
develop  leucocytosis  it  was  concluded  that  neither  the  diluent  nor repeated 
cutting of the  tail had any appreciable  effect. 
Morphology  of the Circulating  Leucocytes in  Pertussis-Injected  Mice.--The 
nature of the cellular elements which contributed to the observed leucocytosis 
was  determined  by  examination  of  Wright-stained  blood  films  obtained  at 
various time periods after the injection of 0.3 ml of pertussls vaccine. 
Two hours after  the  intravenous  injection  of vaccine,  a  pronounced leuco- STEPHEN  I.  MORSE  51 
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penia was  evident  (Fig.  2).  Unlike the initial granulocytopenic response  to 
endotoxin, the main acute effect of pertnssis vaccine was lymphopenia. There 
was an average reduction of 70 per cent in the number of circulating small 
lymphocytes, and  the  large  mononuclears had  decreased by  approximately 
40 per cent. In contrast the number of circulating PMN's had decreased by 
less than 10 per cent. 
Within 4 to 6 hours the leucocyte count rose and the PMN's were predomi- 
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FIo. 2. Changes in the leucocyte counts of mice during the first 72 hours after administra- 
tion of 0.3  ml of pertussis vaccine. 
nant. The total leucocyte count then remained stationary or declined slightly 
during the next 18 hours. However, during that interval the granulocytic ele- 
ments decreased whereas the number and percentage of small  lymphocytes 
increased. 
At the time of the peak response, 4 days after injection, the small lympho- 
cytes comprised 50 to 70 per cent of the leucocyte population (Fig. 3).  These 
cells appeared morphologically normal. The granulocytes accounted for 25 to 
40 per cent of the white blood cells at this time, and these cells were mature 
with typical multilobed nuclei and normal granulation of the cytoplasm. The 
remainder of the cells were large lymphocytes, a few with vacuolated cytoplasm, 
and monocytes. Eosinophiles and basophiles were rarely seen. STEPHEN  I.  MORSE  53 
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As evidenced by the lack of nuclear staining with trypan blue or eosin Y, 
as well as by the brisk locomotion of the leucocytes on glass surfaces, greater 
than 99 per cent of the white cells were considered to be viable. 
Mter the period of maximal leucocytosis, the number of small lymphocytes 
declined, whereas the number of PMN's remained relatively stationary so that 
7 days after injection of pertussis vaccine, the total number of circulating leuco- 
cytes had decreased and the PMN's predominated. During the next 7 days, 
there was a  parallel reduction of all cell types. At no time were abnormal or 
immature cells conspicuous. 
E. coli-contamlnated NCS mice responded somewhat differently to the injec- 
tion of 0.3 ml of pertussis vaccine. Although the magnitude of the lymphocyte 
response was identical with that observed in NCS mice, they tended to have a 
higher total WBC and a more vigorous granulocytic response. 
Hematocrits and reticulocyte counts of mice injected with pertussis vaccine 
were also determined. These values were essentially identical with those of mice 
injected with diluent alone. Moreover, there was no qualitative difference in the 
platelets. 
Comparison of the WBC of Ventricular and Tail Vein Blood of Mice Injected 
with Pertussis Vaccine.--It is well known that the tail vein leucocyte count of 
mice is greater than that of ventricular blood (7). It was therefore necessary to 
compare leucocyte counts from these two sites after administration of pertussis 
vaccine to determine if comparable responses occurred, and to eliminate ana- 
tomical factors as significant components of the observed hyperleucocytosis. 
Mice were injected intravenously with 0.3 ml of pertussis vaccine. At specific 
time intervals, tail vein blood was obtained from each of 4 mice. These mice 
were then killed with chloroform and blood was rapidly sampled from the left 
ventricle. 
As shown in Table I, both leucocytosis and lymphocytosis were demonstrated 
in ventricular as well as in tail vein blood. The ventricular WBC was lower 
both before as well as after injection of pertussis vaccine. However, the relative 
increase in both the total number of leucocytes and small lymphocytes was 
greater in the case of the ventricular samples. These observations indicated that 
tail vein WBC's were  satisfactory indices for determining the leucocyte re- 
sponse to pertussis vaccine. The differences between the central and peripheral 
leucocyte concentrations in  the  mouse  made  it  impossible  to  estimate  the 
absolute number of circulating leucocytes. 
Response  to  Pertussis  Vaccine  Injected  by  Different  Routes.--Injection  of 
pertussis  vaccine  into  mice  renders  them  sensitive  to  the  lethal  effects of 
histamine whereas uninoculated animals are  quite resistant (8).  It is known 
that histamine sensitization is more readily demonstrated following intrave- 
nous administration of vaccine than after other routes  of injection (9,  10). 
Therefore, the leucocyte counts of mice inoculated with vaccine intravenously, 
intraperitoneally, and subcutaneously were compared. STEPHEN  I.  MORSE  55 
Mice were injected with 0.3 mi of pertussis vaccine either by the intravenous, 
intraperitoneal,  or subcutaneous routes; leucocyte counts were performed 1, 4, 
and 7 days later. 
As depicted in Fig. 4,  subcutaneous injection of vaccine resulted in only a 
slight elevation of the leucocyte count. Four days after injection, animals re- 
ceiving  an intraperitoneal  dose of vaccine had  total leucocyte counts which 
were 75 per cent of that observed when the intravenous route was used. How- 
ever, the number of small lymphocytes was only 50 per cent of that seen after 
intravenous injection and the majority of cells were granulocytes. The greater 
polymorphonuclear  response  to  intraperitoneal  injection  may  have  been  a 
consequence of local inflammation. 
TABLE  I 
Leu~ocyte Concentrations in Ventricular and Tail Vein Blood of Mice 
after the Inje,  c~ion of Pertussis Vaccine 
Total WBC/mm  s*  No. of ama!l lymphocyte/ram  s* 
Day 
Ventride  Tail  Ventricle  Tail 
0  8,400  18,400  6,200  14,200 
1  20,700  55,500  15,300  32,100 
4  121,000  191,000  80,300  116,700 
7  93,500  156,000  36,800  65,200 
* Averages of 4 animals. 
Thus, although leucocytosis was seen in both cases, the lymphocyte response 
to pertussis vaccine was twofold greater following intravenous injection than 
following  intraperitoneal  inoculation.  The  subcutaneously administered  dose 
was essentially ineffective. 
It was of particular interest that cells did not accumulate in the peritoneal 
cavity after injection of pertussis vaccine into that site. 
Properties  of Pertussis Vaccine  Which Relate to the Induction of Leucocytosis 
and Lymphocytosis.--Although a complete survey of the leucocyte response to 
pertussis  vaccine  was not  undertaken,  significant  leucocytosis and  lympho- 
cytosis was found to follow the intravenous injection of vaccine into C67 black 
mice, Sprague-Dawley rats, guinea pigs, and New Zealand rabbits. 
The  injection  of comparable  amounts  of pertussis  vaccine obtained from 
other commercial sources (Lederle Laboratories Division, American Cyanamid 
Company, Pearl River, New York, and Parke, Davis and Company, Detroit) 
evoked in mice a leucocytosis in every way comparable to that seen with the 
Lilly product. However, leucocytosis was not produced by the intravenous in- 
jection of a  soluble antigen prepared from phase I  pertussis cells  (UBA, Eli 
Lilly and Company). Injection of equivalent numbers of E. coli, Staphylococcus 
aureus, or cells of a rough strain of B. pertussis did not induce hyperleucocytosis. 56  PERTUSSIS 
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It was found that the leucocytosis-promoting  property of pertussis vaccine 
was associated :with the bacterial cells and not with the suspending  medium. 
The bacilli were sedlmented at 10,000 I~M for 20 minutes and resuspended  to 
volume. 0.3 ml of resuspended bacterial cells or clear vaccine supematant fluid 
were injected intravenously into mice. Leucocytosis followed adminl.qtration of 
the bacteria hut not the injection of the supematant fluid. 
Vaccine  heated  at  I00°C  for 30  minutes no  longer  induced teucocytosis 
whereas complete potency was retained after heating at 56°C for 30 minutes. 
Production of Leucocytosis-Promoting Activity during Growth of B. Pertussis.-- 
Occasional lots of pertnssis  vaccine were less effective than others with respect 
to their ability to produce  leucocytosis. It was possible that variations in the 
level of active material might be a reflection of variations in cultural conditions. 
One  aspect  of this problem was  investigated by studying the leucocytosis- 
inducing activity present in cultures of B. pertussis harvested after different 
growth periods. 
B. pertussls strain 3779]3, utilized in production of the Lilly vaccine,  was 
grown on a modified Cohn-Wheeler charcoal agar medium at 35°C (11). The 
organism fiflfilled the morphological criteria for phase I  and did not grow on 
conventional nutrient media. Slants were inoculated, and at varying time inter- 
vals the growth was washed off with 5.0 ml of physiological saline containing 
thimerosal (1:5000).  The optical density at 650 m# of the suspension was de- 
termined on an appropriately diluted aliquot. 
Mter storage  at 4°C for 5 days the organisms were no longer viable.  The 
suspensions were then diluted to contain 100  X  llY cells/ml, and 0.3 ml was 
injected intravenously into 4 mice. Leucocyte counts were determined 4 days 
later. In addition, the ability of the bacterial cells used for challenge to aggluti- 
nate with pertussis antiserum was examined. Pertnssis antibodies were prepared 
in rabbits by the subcutaneous injection of 0.5 ml of pertnssis  vaccine  three 
times a week for a total of nine injections;  the rabbits were bled 7 days after 
the last inoculation.  Aliquots of the pertnssis  suspensions were mixed with an 
equal volume of antiserum in capillary precipitin tubes and the speed and ex- 
tent of agglutination were qualitatively estimated. 
As indicated in Table II maximum growth was obtained after 72 hours, but 
the maximum capacity of the organism to induce leucocytosis was present after 
48 hours of growth and then dimini.qhed  during further incubation. After 6 days 
of growth no activity was present. It was not clear whether the mechanism of 
inactivation was based upon thermal or other physical or chemical instability, 
or the production by the organisms of an inactivating substance.  Organisms 
harvested at 24 hours could not be adequately tested because they were too 
toxic. Agglutinating capacity of the bacillus seemed to parallel  the ability to 
induce leucocytosis in mice. 
Induction  of Active Immunity against the Leucocytosis Stimulating  Properties 58  PERTUSSIS 
of B. pertussis.--In  order to determine whether the factor responsible for the 
development  of  leucocytosis was  related  to  an  antigenic  component  of  B. 
pertussis, groups of mice were injected with vaccine subcutaneously, and, when 
serum antipertussis antibody was demonstrable these animals were challenged 
intravenously. 
Mice were injected subcutaneously with  two doses of 0.2  ml of pertussis 
vaccine 1 week apart, Seven days later 4 animals were killed and the agglutinin 
content of their sera individually measured. All had titers between 1:320 and 
TABLE II 
The E gent of Incubation Time on the Ability of B. Pertussis Cultures 
to Evoke Leucoeytosis 
Incubation 
days 
2 
O  D~ 
1.8 
5.2 
2.6 
Agglutination 
-4- 
WBC X  10*/mm  s 
145.6 
150.4 
120.0 
53.4 
79.2 
72.4 
80.8 
22.6 
21.8 
24.6 
24.8 
PMN's 
~et ¢~FI4 
30 
24 
35 
32 
22 
25 
22 
24 
15 
17 
24 
Sm~l 
lymphocytes 
pcr cen~ 
6O 
68 
52 
64 
72 
68 
71 
68 
8O 
8O 
71 
i 
* One animal died 48 hours after injection. 
1:1280. Of the remaining mice, 4 received 0.1 ml of pertussis vaccine intrave- 
nously, and 4 received 0.3 ml. Control animals received subcutaneous injections 
of saline  rather than vaccine before intravenous challenge. 
As shown in Fig. 5, actively immunized mice did not respond to either dose 
of the challenge vaccine whereas the control animals had a  typical response. 
In other experiments, it was  found that animals repeatedly injected intra- 
venously with pertussis  vaccine developed leucocytosis after each injection. 
This is in contrast to the protective effect produced by prior subcutaneous in- 
oculations. Preliminary evidence indicated that the levels of antibody produced 
after intravenous injection were much lower than those attained after subcuta- 
neous administration of the vaccine. 
Passive Protection against Pertussis-Induced Leucocytosis.--Attempts to block 
the effects of pertussis vaccine by the prior administration  of hyperimmune STEPIIEIq L  ]wORSE  59 
rabbit antisera gave variable results unless the serum was admixed  with the 
vaccine immediately before injection.  Under those circumstances  there was a 
37 per cent reduction in the peak WBC response; no effect occurred when nor- 
real  rabbit  serum  was  employed.  However,  passive  protection  was  readily 
induced by antipertussis mouse serum. 
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Fro. 5. Leucocyte counts of mice chanenged after immunization  with subcutaneous injec- 
tions of pertussis vaccine. 
A  serum pool was obtained from mice  7 days after the second of 2  weekly 
subcutaneous inoculations of 0.2 ml of pertussis vaccine. The agglutinating titer 
of the pooled serum was  1:320.  0.2 ml of either antipertussis mouse serum or 
normal mouse serum was injected intravenously into 4 mice 24 hours prior to 
the administration of 0.I ml of pertussis vaccine by the intravenous route. 
As shown in Fig.  6, the prior administration of antipertussis serum reduced 
the total WBC rise by 30 per cent and the rise in lymphocytes by 44 per cent 60  PERTUSSIS 
at  the  time  of  the peak  response.  The  results,  although showing less  than 
complete protection were significant. 
The E~rect of Thorotrast on the Leucocyte Response to Pertussis Vaccine.--It 
was of interest to investigate the response to pertussis vaccine following the 
injection of inert particles in order to determine if an adequately functioning 
reticuloendothelial system was required. Thorium dioxide (thorotrast, Testagar 
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FIo. 6. The effect  of 0.1 ml pertussis vaccine  given  intravenously  to mice  which  had received 
antipertussis mouse serum 24 hours previously. 
and Co., Detroit), frequently used for the production of "reticuloendothelial 
blockade," was chosen as the inert material. 
0.02 ml of thorotrast was injected intravenously 45 minutes before the intra- 
venous injection of 0.1  ml of pertussis vaccine. Leucocyte counts were per- 
formed 1, 4, and 7 days later. 
As indicated in Fig. 7, thorotrast administration reduced but did not abolish 
the leucocytosis. 
Attempts to Transfer Leucocytosis with Serum and Organ Extracts of Pertussis 
Injected  Mice.--The results with thorotrast suggested that before leucocytosis 
can develop, the organism must be phagocyted by the cells of the reticuloendo- STEPHEN  I.  MORSE  61 
thelial system. Perhaps either a soluble bacterial product is then released which 
induces leucocytosis directly or there is indirect stimulation of the production 
of an endogenous leucocytosis factor. Numerous studies were devised in an 
attempt to demonstrate a soluble leucocytosis factor in the reficuloendothelial 
tissue or circulation of mice which had received pertussis vaccine. Samples were 
obtained at time periods ranging from a few hours to 3 days after vaccine ad- 
ministration. In no instance was serum, or extracts of liver and spleen from 
inoculated animals capable of transferring leucocytosis. 
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FIo. 7. The effect of thorotrast  on the leucocyte response of mice injected intravenously 
with pertussis vaccine. 
The  Effects  of  Thymectomy  and  Splenectomy  on  the  Response to  Pertnssis 
Vaccine.--I_f the effect of pertussis vaccine was to stimulate the production of 
an endogenous leucocytopoietic or leucocyte releasing factor, removal of the 
target  organ might modify the leucocyte response.  Therefore  the  effects  of 
extirpation of two organs known to affect leucocyte regulation, the spleen, and 
the thymus, were studied. 
Two groups of mice were thymectomized at 4 weeks of age. One group was 
given pertussis  vaccine 9  days after operation and the  other  13  days after 62  PF.RTUSSIS 
thymus ablation. The challenge  dose was 0.1 ml of pertussis vaccine in both 
instances. 
Although a slight lymphopenia was present at the time of vaccine injection, 
both groups of mice responded with a leucocytosis and lymphocytosis compara- 
ble to that  in normal animals. 
Six  splenectomized  and  6  sham-operated  mice  were  also  challenged  with 
0.1  ml of pertussis vaccine  10 days after operation.  The  resulting  leucocyte 
response is shown in Fig. 8. 
The total WBC was higher  in the splenectomized  animals,  and the rate of 
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FIo. 8. The effect of spleneetomy on the leucocyte response of mice injected with pertussis 
vaccine. 
decline was slower than in the sham-operated controls.  The difference in total 
leucocytes was virtually all due to a greater increase  in circulating PMN's in 
the splenectomized animals.  Histological studies indicated that  PMN's were 
present in large numbers in the splenic red pulp of the intact animals.  Therefore 
the lack of splenic sequestration of cells might have caused both the greater 
elevation and slower fall of the leucocyte counts of splenectomlzed animals. 
Changes ~n  the Lymphoid  and HematopoieEc  Organs of Mice  Injected  with 
Pertussis Vaccine.--In order to provide more intimate knowledge of the mecha- 
nism of leucocytosis and lymphocytosis produced by B.  pertussis,  gross  and 
microscopic  studies of various tissues of injected mice were performed. 
Twenty mice were injected intravenously with 0.3 ml of pertussis vaccine. 
One,  4,  7, and 14 days after injection, 5 mice were killed by chloroform anes- 
thesia.  The weights of the thymus, spleen,  and mesenteric node (pancreas of SI'EPIIEN  I.  MORSE  63 
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Aselli) were determined. The lymphoid organs, as well as samples of liver, lung, 
kidney, and adrenal gland were fixed in 10 per cent formalin for histologic ex- 
amination. Twenty litter mates received 0.3 ml of diluent injected intravenously 
and were killed at the same time intervals. These mice served as experimental 
controls. Another group of 5 litter-mates served as zero time controls. 
Fig. 9 illustrates the changes in the weights of the lymphoid organs after the 
intravenous injection of vaccine. There was a  dramatic fall in thymus weight 
and by the 4th day after vaccine injection, the average thymus weight was 
approximately 35 per cent of the control. The loss of thymic weight persisted 
for the duration of the experimental period. 
The mesenteric nodes which were removed en bloc and trimmed of excess fat 
also decreased in weight. However, the extent and duration of the weight loss 
was less than that of the thymus. The nodes weighed 70 and 57 per cent of 
normal at the 4th and 7th day after injection respectively. However, by the 
14th day they were of normal weight. 
In contrast to the response of the thymus and nodes, the spleens of pertussis- 
inoculated animals markedly increased in size and weight (Fig. 9). 
On microscopic examination, the most obvious changes in the lymph node 
were  disruption of follicular architecture; loss  of distinction between cortex 
and  medulla;  and  decrease  in  the  quantity  of  lymphocytic elements.  The 
changes were not seen at 1 day after injection but were prominent 4 days after 
the injection of pertussis vaccine. By the  14th day a  few normal  appearing 
follicles were present. 
In the case of the thymus, there was a striking loss of normal thymocytes by 
the 4th day and the reticular cells were prominent. There was also little de- 
marcation between the cortex and medulla; again by the 14th day groups of 
small mononuclear cells, poorly organized, were found. 
The  spleens  of  the  experimental animals  showed  the  same  changes  with 
respect to disorganization of follicles and diminution in quantity of lymphoid 
cells as seen in the lymph node and thymus. In addition, however, there was a 
marked  increase  in  red  pulp  with  numerous  polymorphonuclear leucocytes 
present in  the  sinusoidal spaces.  The  increase  in  red pulp  almost  certainly 
accounted for the observed increase in spleen weight. 
Representative  sections  were  also  stained  by  the  methyl green-pyronine 
method. Mitotic figures were no more numerous in the thymus, lymph node, 
or spleen of experimental animals than in the controls during the course of the 
experiment. 
It was of great interest that typical germinal centers were not seen,  an ob- 
servation that correlated with the finding that normal levels of antibody were 
not formed after intravenous injection of pertussis vaccine. In contrast sections 
of lymph nodes and spleens of mice receiving subcutaneous injections of per- 
tussis  vaccine  did  show  changes  characteristic  of  stimulation  of  antibody 
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Examination of bone marrow from pertussis-injected mice showed moderate 
increase  in  the  cells  of the granulocytic series  and  virtual  absence of small 
lymphocytes.  There  were  no  significant  gross  or  microscopic  abnormalities 
noted in the other organs examined and no abnormalities  were found in the 
tissues of mice receiving  diluent alone. 
DISCUSSION 
Phase I  cells of Bordetella pertussis are capable of inducing  a variety of bio- 
logical  changes  in  experimental  animals.  These  changes  include  enhanced 
sensitivity to histamine,  serotonin, and other pharmacological agents as well 
as  increased  susceptibility to  anaphylaxis  (8,  12-14).  In  addition,  pertussis 
vaccine has an adjuvant effect (15). 
Another property of the organism is the ability to induce leucocytosis with a 
predominating  lymphocytosis.  This  type  of  reaction  is  rarely  seen  in  bac- 
terial diseases although it does occur occasionally in patients with tuberculosis 
or  either  secondary or congenital  syphilis.  Lymphocytosis is  commonly ob- 
served in  certain  viral  infections  particularly  mumps,  measles,  and  disease 
caused by type 12 adenovirus (16). 
Many hypotheses have been presented to account for the pertussis-associated 
lymphocytosis. An early theory suggested that the paroxysmal coughing  liter- 
ally squeezed the lymphocytes from the lymphatics into the circulation.  This 
postulate is untenable since lymphocytosis can be induced in man and experi- 
mental animals by the injection of killed vaccine. 
Adrenal  cortical insufficiency  has also been invoked as an explanation  for 
the  lymphocytosis. However,  lymphocytosis of  this  degree  is  not  noted  in 
patients with Addison's disease.  Moreover, adrenalectomized rats maintained 
only on mineral corticoid give a response comparable to normal rats after an 
injection of pertussis vaccine (17).  In addition, in the present study no histo- 
logical  changes were noted in the adrenals. 
It has previously been shown that injection of sonic extracts of B. pertussis 
into rabbits results in a  leucocytosis and lymphocytosis (4).  Heating of the 
sonic extract for 30 minutes diminished  the lymphocytosls and a predomlnately 
granulocytic response occurred. Bradford and his coworkers studied the leuco- 
cyte changes in mice consequent to the intraperitoneal  injection of sonic ex- 
tracts of B. pertussis cells 3 weeks after initiation of intrapulmonary infection. 
They observed a striking leucocytosis 3 days after intraperitoneal injection of 
unheated sonic extract  (18).  Many of the observed responses were primarily 
granulocytic. 
In the studies presented in this report, several observations have been made 
regarding  the nature of the leucocyte response in mice which follows  the in- 
jection of pertussis vaccine. Although the relative increase in granulocytes is 
large after the injection of pertussis bacilli  it is the mature, small lymphocyte 
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respect to both the PMN's and lymphocytes, is far greater than that seen after 
the injection of other organisms. There is also an increase in the numbers of 
circulating  large lymphocytes and monocytes. There is no significant  change 
in cells of the erythrocytic series. 
The route of injection is of considerable importance. Intraperitoneal injection 
is less effective than the intravenous route in inducing  leucocytosis, but the 
results  are complicated  by the development  of an inflammatory focus in the 
peritoneal cavity. Subcutaneous  injection is  virtually without effect  on the 
peripheral  leucocyte count. It is difficult to assess the factors which make the 
subcutaneous route ineffective. The local destruction of bacterial products by 
tissue  enzymes,  or  a  different  distribution of injected material may be  re- 
sponsible. 
That the distribution of the inoculum is of importance is suggested by the 
results  obtained with thorotrast. Whether the "reticuloendothelial blockage" 
induced by thorotrast is due to loading of phagocytic cells, or removal of circu- 
lating opsonins, the net effect is to retard uptake of particles  by fixed phago- 
cytes.  Therefore  the  diminution of both  granulocytosis  and  lymphocytosis 
strongly suggests that the factor(s)  involved  is the product of an interaction 
between  these cells and the injected bacteria. 
Such an interaction might result in the release of an endogenous substance 
which in turn stimulates leucocytosis. Leucocytosis  was not induced in mice 
receiving serum or organ extracts from previously inoculated animals suggesting 
that the hypothetical factor may be present only in small  quantifies in the 
circulation  or is rapidly fixed to tissues. Since neither prior thymectomy nor 
splenectomy reduced the leucocytosis, an endogenous substance could not arise 
solely from these organs. 
Alternatively, the interaction between the organism and the phagocytic cells 
might result in the liberation  of a soluble bacterial product which then evokes 
the white cell response. Highly active material has been obtained in this labora- 
tory following fractionation of sonic extracts of B. pcrtussis  cells and studies 
are in progress to elucidate the first step in the pertussis-induced  leucocytosis. 
The inability of actively or passively immlmlzed mice to respond  with the 
usual leucocytosis indicates  that the component of B. pertussis  that induces 
the reaction may be antigenic.  Alternatively, the presence of antibody could 
affect the distribution of the organisms and their processing by host tissues and 
cells so that active material is not released. 
The leucocytosis-promoting  properties  of pertussis  vaccine  bears  many re- 
semblances to the histamine-sensitizing  properties:  heat lability; time of peak 
response; and heightened effect by the intravenous route of injection (9,  10). 
However, purified preparations have not been isolated and it can not be deter- 
mined if the  leucocytosis  factor is  related to any known constituent of B. 
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It is not known whether the leucocytosis is due to the release or production 
of new ceils, or a combination of both events. Bone marrow examination showed 
increased granulocytopoietic activity, but immature PMN's were not apparent 
in the circulation  suggesting  that the granulocytic phase may be due to the 
operation of both factors. 
Histologic changes in the bone marrow and the lymphoid organs,--thymus, 
lymph node, and spleen,---suggested that the lymphocytosis  may be due to the 
release  of formed small lymphocytes into  the  circulation.  The  tissues  were 
virtually denuded of small lymphocytes and there was no evidence of cellular 
debris  and mononuciear  phagocytosis  which is seen when lymphoid tissue  is 
destroyed by x-irradiation (6). Moreover mitotic figures were no more promi- 
nent in the experimental  group  than in  the  controls  again suggesting  that 
production of new cells is not a major factor. It has been estimated that there 
is an accessible reserve of small lymphocytes which is 40 times greater than the 
number of these cells in the circulation  (19). Thus far there is no evidence that 
lymphatic blockage plays a role in the observed phenomena. 
The fate of the lymphocytes which appear in the circulation  is not clear. 
Two weeks after the injection of pertnssis vaccine, there was beginning repopu- 
lation of the lymphoid organs with lymphocytes, but the number of mitotic 
figures was not increased;  it is therefore possible that the circulating lympho- 
cytes may "home." 
Studies  now in progress  are designed to isolate  and characterize  the com- 
ponent of B. pertussis which produces the leucocyte response and to elucidate 
further the dynamics of the phenomenon. 
SU'M-ta  ~.Ry 
1.  Intravenous injection into mice of phase I  Bordadla  pertussis vaccine 
resulted in a striking hyperleucocytosis  with a predominating lymphocytosis. 
Intraperitoneal inoculation was less effective, and subcutaneous administra- 
tion was inactive. 
2.  Active immunization prevented the hyperleucocytosis;  passive immuniza- 
tion was less effective. 
3.  Reticuloendothelial blockage reduced the effect of the vaccine. 
4.  Extirpation of the spleen or thymus did not alter the leucocyte response. 
5.  Histologic studies suggested that the increase in circulating  lymphocytes 
resulted from release  of cells from lymphoid organs,  including the  thymus. 
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